The POWER and TITAN trials: darunavir/ritonavir in the management of HIV-infected patients

ISSN： 1746-9600

Source： Future HIV Therapy, Vol.2, Iss.3, 2008-05, pp. : 229-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The DUET trials: etravirine in the management of treatment-experienced HIV-1-infected patients

By Mills Anthony M

HIV Therapy, Vol. 4, Iss. 3, 2010-05 ,pp. : 265-280

Future Medicine

Access to resources Recommend Favorite

Fat Tissue Distribution Changes in HIV-Infected Patients Treated with Lopinavir/Ritonavir. Results of the MONARK Trial

Current HIV Research, Vol. 9, Iss. 1, 2011-01 ,pp. : 31-39

Bentham Science Publishers

Access to resources Recommend Favorite

Neurosyphilis in HIV-infected patients

By Philip Susan S Klausner Jeffrey D

Future HIV Therapy, Vol. 2, Iss. 6, 2008-11 ,pp. : 595-602

Future Medicine

Access to resources Recommend Favorite

ART outcome in HIV-infected patients

By Manigart Y. Rozenberg S. Barlow P. Gerard M. Bertrand E. Delvigne A.

Human Reproduction, Vol. 21, Iss. 11, 2006-11 ,pp. : 2935-2940

Oxford University Press

Access to resources Recommend Favorite

Oral Candidosis in HIV-Infected Patients

Current HIV Research, Vol. 6, Iss. 6, 2008-11 ,pp. : 485-499

Bentham Science Publishers

Access to resources Recommend Favorite